Fig. 3From: Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticlesConverted α-synuclein concentration φα-syn,IMR versus spiked α-synuclein concentration φα-syn in PBS solution for the analysis of dynamic range for assaying α-synucleinBack to article page